34871222|t|Influence of genetic variants of opioid-related genes on opioid-induced adverse effects in patients with lung cancer: A STROBE-compliant observational study.
34871222|a|ABSTRACT: Despite the dramatic advancement of cancer chemotherapy and immunotherapy, the insufficient progress has been made in basic or translational research on personalization of opioid therapy. Predicting the effectiveness of opioid analgesic therapy and the risk of adverse effects prior to therapy are expected to enable safer and more appropriate opioid therapy for cancer patients. In this study, we compared the incidence of opioid-induced adverse effects between patients with different variants of the genes related to responsiveness to opioid analgesics.Participants were 88 patients with lung cancer who provided general consent for exome sequencing and were treated with morphine or oxycodone at Shizuoka Cancer Center Hospital between April 2014 and August 2018. Incidence rates for 6 adverse effects of opioid therapy (somnolence, nausea, constipation, delirium, urinary retention, and pruritus) were determined and the influence of single nucleotide polymorphisms in coding regions of the opioid mu receptor 1 (OPRM1) (rs1799971), opioid delta receptor 1 (rs2234918), opioid kappa receptor 1 (rs1051660), catechol-O-methyltransferase (COMT) (rs4680), dopamine receptor D2 (rs6275), adenosine triphosphate binding cassette B1 (rs1045642), G-protein regulated inward rectifier potassium channel 2 (rs2070995), and fatty acid amide hydrolase (rs324420) genes on those adverse effects were analyzed.Analysis of OPRM1 gene variant status (Asn133Asp A > G) showed that G/G homozygotes were at significantly lower risk of somnolence compared with A allele carriers (0% vs 28.4%; Fisher exact test, P = .005; OR, 0; 95% CI, 0-0.6), and analysis of COMT gene variant status (Val158Met, G > A) showed that G/G homozygotes were at significantly higher risk of somnolence compared with A allele carriers (35.0% vs 10.4%; Fisher exact test, P = .008; OR, 4.5; 95% CI, 1.4-18.1). No relationship between variant status and adverse effects was found for the other genes.These findings demonstrate that OPRM1 and COMT gene variants influence the risk of somnolence as an adverse effect of opioid analgesic therapy.
34871222	72	87	adverse effects	Disease	MESH:D064420
34871222	91	99	patients	Species	9606
34871222	105	116	lung cancer	Disease	MESH:D008175
34871222	204	210	cancer	Disease	MESH:D009369
34871222	429	444	adverse effects	Disease	MESH:D064420
34871222	531	537	cancer	Disease	MESH:D009369
34871222	538	546	patients	Species	9606
34871222	607	622	adverse effects	Disease	MESH:D064420
34871222	631	639	patients	Species	9606
34871222	745	753	patients	Species	9606
34871222	759	770	lung cancer	Disease	MESH:D008175
34871222	843	851	morphine	Chemical	MESH:D009020
34871222	855	864	oxycodone	Chemical	MESH:D010098
34871222	877	883	Cancer	Disease	MESH:D009369
34871222	958	973	adverse effects	Disease	MESH:D064420
34871222	993	1003	somnolence	Disease	MESH:D006970
34871222	1005	1011	nausea	Disease	MESH:D009325
34871222	1013	1025	constipation	Disease	MESH:D003248
34871222	1027	1035	delirium	Disease	MESH:D003693
34871222	1037	1054	urinary retention	Disease	MESH:D016055
34871222	1060	1068	pruritus	Disease	MESH:D011537
34871222	1186	1191	OPRM1	Gene	4988
34871222	1194	1203	rs1799971	SNP	tmVar:rs1799971;VariantGroup:1;CorrespondingGene:4988;RS#:1799971;CorrespondingSpecies:9606
34871222	1231	1240	rs2234918	SNP	tmVar:rs2234918;VariantGroup:4;CorrespondingGene:4985;RS#:2234918;CorrespondingSpecies:9606
34871222	1268	1277	rs1051660	SNP	tmVar:rs1051660;VariantGroup:5;CorrespondingGene:4986;RS#:1051660;CorrespondingSpecies:9606
34871222	1280	1308	catechol-O-methyltransferase	Gene	1312
34871222	1310	1314	COMT	Gene	1312
34871222	1317	1323	rs4680	SNP	tmVar:rs4680;VariantGroup:0;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606
34871222	1326	1346	dopamine receptor D2	Gene	1813
34871222	1348	1354	rs6275	SNP	tmVar:rs6275;VariantGroup:7;CorrespondingGene:1813;RS#:6275;CorrespondingSpecies:9606
34871222	1357	1399	adenosine triphosphate binding cassette B1	Gene	5243
34871222	1401	1410	rs1045642	SNP	tmVar:rs1045642;VariantGroup:2;CorrespondingGene:5243;RS#:1045642;CorrespondingSpecies:9606
34871222	1471	1480	rs2070995	SNP	tmVar:rs2070995;VariantGroup:6;CorrespondingGene:3763;RS#:2070995;CorrespondingSpecies:9606
34871222	1487	1513	fatty acid amide hydrolase	Gene	2166
34871222	1515	1523	rs324420	SNP	tmVar:rs324420;VariantGroup:3;CorrespondingGene:2166;RS#:324420;CorrespondingSpecies:9606
34871222	1540	1555	adverse effects	Disease	MESH:D064420
34871222	1582	1587	OPRM1	Gene	4988
34871222	1609	1624	Asn133Asp A > G	ProteinMutation	tmVar:p|SUB|N,D|133|A,G;HGVS:p.N,D133A,G;VariantGroup:8;CorrespondingGene:4988;CorrespondingSpecies:9606
34871222	1690	1700	somnolence	Disease	MESH:D006970
34871222	1815	1819	COMT	Gene	1312
34871222	1841	1850	Val158Met	ProteinMutation	tmVar:p|SUB|V|158|M;HGVS:p.V158M;VariantGroup:0;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606;CA#:127287
34871222	1852	1857	G > A	DNAMutation	tmVar:c|SUB|G||A;VariantGroup:9;CorrespondingGene:1312;CorrespondingSpecies:9606
34871222	1924	1934	somnolence	Disease	MESH:D006970
34871222	2084	2099	adverse effects	Disease	MESH:D064420
34871222	2162	2167	OPRM1	Gene	4988
34871222	2172	2176	COMT	Gene	1312
34871222	2213	2223	somnolence	Disease	MESH:D006970
34871222	Negative_Correlation	MESH:D010098	MESH:D008175
34871222	Positive_Correlation	MESH:D006970	1312
34871222	Association	MESH:D064420	RS#:324420;CorrespondingGene:2166
34871222	Association	MESH:D064420	RS#:2070995;CorrespondingGene:3763
34871222	Positive_Correlation	MESH:D006970	RS#:4680;HGVS:p.V158M;CorrespondingGene:1312
34871222	Positive_Correlation	CorrespondingGene:1312;CorrespondingSpecies:9606;VariantGroup:9;tmVar:c	MESH:D006970
34871222	Negative_Correlation	MESH:D009020	MESH:D009369
34871222	Negative_Correlation	MESH:D006970	HGVS:p.N,D133A,G;CorrespondingGene:4988
34871222	Negative_Correlation	MESH:D006970	RS#:1799971;CorrespondingGene:4988
34871222	Negative_Correlation	MESH:D009020	MESH:D008175
34871222	Negative_Correlation	MESH:D010098	MESH:D009369
34871222	Positive_Correlation	RS#:4680;CorrespondingGene:1312	MESH:D006970
34871222	Positive_Correlation	MESH:D006970	RS#:4680;CorrespondingGene:1312
34871222	Association	MESH:D064420	2166
34871222	Association	MESH:D064420	3763
34871222	Association	MESH:D006970	1312
34871222	Association	MESH:D006970	4988

